Interactive endogenous small molecule (gaseous) signaling: Implications for teratogenesis

Current Pharmaceutical Design

Volumn 13, Issue 29, 2007, Pages 2952-2978

  Fukuto, Jon M ^a   Collins, Michael D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbon monoxide; Dioxygen; Hydrogen sulfide; Nitric oxide; Signal transduction; Teratogenesis

Indexed keywords

CARBON DIOXIDE; CYTOCHROME C OXIDASE; GROWTH FACTOR RECEPTOR; HYDROGEN SULFIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; METALLOPROTEIN; NITRIC OXIDE; OXYGEN; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR; TYROSINE KINASE RECEPTOR;

BIOCHEMISTRY; BIOENERGY; CHEMICAL TERATOGENESIS; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; FETOTOXICITY; GAS; HUMAN; HYPEROXIA; HYPOXIA; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; OXYGEN SENSING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TERATOGENICITY;

ANIMALS; CARBON DIOXIDE; GASES; HUMANS; HYDROGEN SULFIDE; NITRIC OXIDE; OXYGEN; SIGNAL TRANSDUCTION; TERATOGENS;

EID: 36248940497     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207782110525     Document Type: Review

References (378)

1. Pryor WA, Houk KN, Foote CS, Fukuto JM, Ignarro LJ, Squadrito GL, et al. Free radical biology and medicine: It's a gas, man. Am J Physiol Regulatory Int Com Physiol 2006; 291: 491-511.
2. Kashiba M, Kajimura M, Goda N, Suematsu M. From O2 to H2S: A landscape view of gas biology. Keio J Med 2002; 51 (1): 1-10.
3. Committee on Developmental Toxicology, National Research Council Scientific frontiers in developmental toxicology and risk assessment. Washington, D. C., National Academy Press, 2000.
4. Valentine JS, Wertz DL, Lyons TJ, Liou LL, Goto JJ, Gralla EB. The dark side of dioxygen biochemistry. Curr Opin Chem Biol 1998; 2: 253-62.
5. Sawyer DT. Oxygen chemistry. New York, Oxford University Press 1991.
6. Ho RYN, Liebman JF, Valentine JS. Overview of the energetics and reactivity of oxygen (Chapter 1). In: Foote CS, Valentine JS, Greenberg A, Liebman JF Eds, Active oxygen chemistry. London, Blackie Academic and Professional 1995; 1-23.
7. Foote CS, Clennan EL. Properties and reactions of singlet oxygen (Chapter 4). In: Foote CS, Valentine JS, Greenberg A and Liebman JF, Eds. Active oxygen chemistry. London, Blackie Academic and Professional 1995: 105-40.
8. Ho RYN, Liebman JF, Valentine JS. Biological reactions of dioxygen: An introduction. In: Valentine JS, Foote CS, Greenberg A, Liebman JF Eds, Active oxygen in biochemistry. London, Blackie Academic and Professional 1995; 1-36.
9. Yoshikawa S. Reducing dioxygen to water: Cytochrome c oxidase (Chapter XI.6). In: Bertini I, Gray HB, Stiefel EI, Valentine JS Eds, Biological inorganic chemistry, structure and reactivity. Sausalito, University Science Books 2006; 413-26.
10. Denisov IG, Makris TM, Sligar SG, Schlichting I. Structure and chemistry of cytochrome P450. Chem Rev 2005; 105: 2253-77.
11. Yin H, Porter NA. New insights regarding the autoxidation. of polyunsaturated fatty acids. Antiox Redox Signal 2005; 7(1,2): 170-84.
12. Basu S. Isoprostanes: Novel bioactive products of lipid peroxidation. Free Rad Res 2004; 38(2): 105-22.
13. Awasthi YC, Sharma R, Cheng JZ, Yang Y, Sharma A, Singhal SS, et al. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Asp Med 2003; 24:219-30.
14. Sawyer DT, Valentine JS. How super is superoxide? Ace Chem Res 1981; 14: 393-400.
15. Flint DH, Allen RM. Iron-sulfur proteins with nonredox functions Chem Rev 1996; 96: 2315-34.
16. Forman HJ, Fukuto JM and Torres M. Redox signaling: Thiol chemistry defines which rective oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 2004; 287: C246-56.
17. Stone JR, Yang S. Hydrogen peroxide: A signaling messenger. Antiox Redox Signal 2006; 8(3,4): 243-70.
18. Jacob C, Giles GI, Giles NM, Sies H. Sulfur and selenium: The role of oxidation state in protein structure and function. Angew Chem Int Ed 2003; 42: 4742-58.
19. Stone JR. An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems. Arch Biochem Biophys 2004; 422: 119-24
20. Mason HS. Mechanisms of oxygen metabolism. Science 1957; 125: 1185-8.
21. Morriss GM, New DA. Effect of oxygen concentration on morphogenesis of cranial neural folds and neural crest in cultured embryos. J Embryol Exp Morphol 1979; 54: 17-35.
22. 2 pressures. Pflüg Archiv Eur J Physiol 1975; 359: 81-95.
23. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992; 80(2): 283-85.
24. Cowden Dahl KD, Fryer BH, Mack FA, Compernolle V, Maltepe E, Adelman DM, et al. Hypoxia-inducible factors 1a and 2a regulate trophoblast differentiation. Mol Cell Biol 2005; 25(23): 10479-91.
25. Hirao M, Tamai N, Tsumaki N, Yoshikawa H, Myoui A. Oxygen tension regulates chondrocyte dfferentiation and function during endochondral ossification. J Biol Chem 2006; 281(41): 31079-92.
26. Colnot C. Cellular and molecular interactions regulating skeleto-genesis. J Cell Biochem 2005; 95: 688-97.
27. Wikenheiser J, Doughman Y-Q, Fisher SA, Watanabe M. Differential levels of tissue hypoxia in the developing chicken heart. Dev Dyn 2006; 235: 115-23.
28. Miki A, Fujimoto E, Ohsaki T, Mizoguti H. Effects of oxygen concentration on embryonic deve4opment in rats: A light and electron microscopic study using whole-embryo culture techniques. Anat Embryol (Berl) 1988; 178: 337-43.
29. Ishibashi M, Akazawa S, Sakamaki H, Matsumoto K, Yamasaki H, Yamaguchi Y, et al. Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis. Free Rad Biol Med 1997; 22(3) 447-54.
30. Shepard TH, Tanimura T, Robkin MA. Energy metabolism in early mammalian embryos. Dev Biol Suppl 1970; 4:42-58.
31. Burton GJ, Jauniaux E. Maternal vascularization of the human placenta: does the embryo develop in a hypoxic environment? Gynecol Obstet Fertil 2001; 29(7-8): 503-08.
32. Jauniaux E, Watson A, Burton G. Evaluation of respiratory gases and acid-base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks' gestation. Am J Obstet Gynecol 2001; 184(5): 998-1003.
33. Jauniaux E, Gulbis B, Burton GJ. Physiological implications of the materno-fetal oxygen gradient in human early pregnancy. Reprod Biomed Online 2003; 7(2): 250-3.
34. Juniaux E, Gulbis B, Burton GJ. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus - a review. Placenta 2003b; 24(Suppl A): S86-93.
35. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, et al. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development. Dev Dyn 2001; 220(2):175-86.
36. Ryan HE, Lo J, Johnson RS. HEF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17(11): 3005-15.
37. Rizzo AM, Adorni L, Montorfano G, Rossi F, Berra B. Antioxidant metabolism of Xenopus laevis embryos during the first days of development. Comparative Biochem Physiol B Biochem Mol Biol 2007; 146: 94-100.
38. Baumann R, Dragon S. Erythropoiesis and red cell function in vertebrate embryos. Eur J Clin Invest 2005; 35(Suppl 3): 2-12.
39. Burggren WW. What is the purpose of the embryonic heart beat? Or how facts can ultimately prevail over physiological dogma. Physiol Biochem Zoology 2004; 77(3): 333-45.
40. Weir EK, López-Barneo J, Buckler KJ, Archer SL. Acute oxygen-sensing mechanisms. N Engl J Med 2005; 353(19): 2042-55.
41. Alzamora-Castro V, Battilana G, Abugattas R, Sialer S. Patent ductus arteriosus and high altitude. Am J Cardiol 1960; 5: 761-3.
42. Palmer SK, Moore LG, Young D, Gregger B, Berman JC, Zamudio S. Altered blood pressure course during normal preganancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol 1999; 180: 1161-8.
43. Yip R, Binkin NJ, Trowbridge FL. Altitude and childhood growth. J Pediatr 1988; 113(3): 486-9.
44. Unger C, Weiser JK, McCullough RE, Keefer S, Moore LG. Altitude, low birth weight, and infant mortality in Colorado. JAMA 1988; 259(23): 3427-32.
45. Moore LG. Fetal growth restriction and maternal oxygen transport during high altitude preganancy. High Alt Med Biol 2003; 4(2): 141-56.
46. Hampl V, Bibova J, Stranak E, Wu X, Michelakis ED, Hashimoto K, et al. Hypoxic fetoplacental vasoconstriction in humans is mediated by potassium channel inhibition. Am J Physiol Heart Circ Physiol 2002; 283(6): H2440-9.
47. Bournaud R, Hidalgo J, Yu H, Girard E, Shimahara T. Catecholamine secretion from rat foetal adrenal chromaffin cells and hypoxia sensitivity. Pflugers Arch 2007; 454(1): 83-92.
48. Tyzio R, Cossart R, Khalilov I, Minlebaev M, Hübner CA, Represa A, et al. Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science 2006; 314: 1788-92.
49. Kaelin WG Jr. Proline hydroxylation and gene expression. Annu Rev Biochem. 2005; 74: 115-28.
50. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997; 94(9): 4273-8.
51. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72-82.
52. Wang GL, Jiang B-H, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92(12): 5510-4.
53. Ramirez-Bergeron DL, Runge A, Adelman DM, Gohil M, Simon MC. HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Dev Cell 2006; 11(1): 81-92.
54. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1 alpha (HIF-1-alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23(24): 9361-74.
55. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, Johnson RS. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): Role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 2003; 23(14): 4959-71.
56. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 2003; 63(19): 6130-4.
57. Heidbreder M, Frohlich F, Johren O, Dendorfer A, Qadri F, Dominiak P. Hypoxia rapidly activates HIF-3α mRNA expression. FASEB J 2003; 17: 1541-3.
58. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, et al. Inhibitory PAS domain is a negative regulator of hypoxia-inducible gene expression, Nature 2001; 414(6863): 550-4.
59. Makino Y, Kanopka A, Wilson WJ, Tanaka H, Poellinger L. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J Biol Chem 2002; 277(36): 32405-8.
60. Pouysségur J, Dayan F, Mazure NM. Hypoxia signaling in cancer and approaches to enforce tumor regression. Nature 2006; 441: 437-43.
61. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA-binding activity by hypoxia. J Biol Chem 1993; 268(29): 21513-8.
62. Okino ST, Chichester CH, Whitlock JP Jr. Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter. J Biol Chem 1998; 273(37): 23837-43.
63. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002; 16(10): 1151-62.
64. Berra E, Roux D, Richard DE, Pouysségur J. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteosomal degradation irrespective of its subcellular localization: Nucleus or cytoplasm. EMBO Rep 2001; 2(7): 615-20.
65. Schofield CJ, Ratcliffe PJ. Signalling hypoxia by HIF hydroxylases. Biochem Biophys Res Commun 2005; 318(1): 617-26.
66. Mailhos C, Modlich U, Lewis J, Harris A, Bicknell R, Ish-Horowicz D. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 2001; 69(2-3): 135-44.
67. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 2005; 65(19): 8690-7.
68. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, et al. Hypoxia requires Notch signaling to maintain the undifferentiated cell state. Dev Cell 2005; 9: 617-28.
69. Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G, et al. Hypoxia-mediated activation of D114-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 2007; 313: 1-9.
70. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996; 76(3): 839-85.
71. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 2006; 91(5): 807-19.
72. Jensen PK. Antimycin-insensitive oxidation of succinate and reduced nicotinamide-adenine dinucleotide in electron transport particles. Biochim Biophys Acta, 1966; 122: 157-66.
73. Chandel NS, Budinger GR, Schumacker PT. Molecular oxygen modulates cytochrome c oxidase function. J Biol Chem 1996; 271(31): 18672-7.
74. Chandel NS, Budinger GR, Choe SH, Schumacker PT. Cellular respiration during hypoxia. Role of cytochrome oxidase as the oxygen sensor in hepatocytes. J Biol Chem 1997, 272(30): 18808-16.
75. Chandel N, Budinger GR, Kemp RA, Schumacker PT. Inhibition of cytochrome-c oxidase activity during prolonged hypoxia. Am J Physiol 1995; 268(6 Pt 1): L918-25.
76. 2 sensor. J Biol Chem 1998; 273(6): 3320-6.
77. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552: 335-44.
78. Wyatt CN, Buckler KJ. The effect of mitochondrial inhibitors on membrane currents in isolated neonatal rat carotid body type I cells. J Physiol 2004; 556: 175-91.
79. Baysal BE. A phenotypic perspective on Mammalian oxygen sensor candidates. Ann NY Acad Sci 2006; 1073: 221-33.
80. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8 (5/6): 691-728.
81. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87(1): 245-313.
82. + flux. Nature 2002; 416: 291-7.
83. 2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta, 1986; 853(1): 65-89.
84. + current modulation in wild type and oxidase deficient mice. Proc Natl Acad Sci USA 2000; 97(8): 4374-9.
85. Kazemian P, Stephenson R, Yeger H, Cutz E. Respiratory control in neonatal mice with NADPH oxidase deficiency. Resp Physiol 2001; 126:89-101.
86. i and respiratory responses to hypoxia. Brain Res 2000; 872: 188-93.
87. Archer SL, Reeve HL, Michelakis E, Puttagunta L, Waite R, Nelson DP, et al. O2 sensing is presenrved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc Natl Acad Sci USA 1999; 96(14): 7944-9.
88. Sanders KA, Sundar KM, He L, Dinger B, Fidone S, Hoidal JR. Role of components of the phagocytic NADPH oxidase in oxygen sensmg. J Appl Physiol 2002; 93: 1357-64.
89. He L, Dinger B, Sanders K, Hoidal J, Obeso A, Stensaas L, Fidone S, Gonzalez C. Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells. Am J Physiol Lung Cell Mol Physiol 2005; 289: L916-24.
90. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Riccardi D, et al. Hemeoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 2004; 306: 2093-7.
91. Evans AM, Mustard KJ, Wyatt CN, Peers C, Dipp M, Kumar P, et al. Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells? J Biol Chem 2005; 280(50): 41504-11.
92. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keapl-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47: 89-116.
93. Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 2004; 24(19): 8477-86.
94. Kobayashi A, Kang M-I, Okawa H, Ohtsuji M, Zenke Y, Chiba T, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004; 24: 7130-9.
95. Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 2004; 24: 10941-53.
96. Jain AK, Jaiswal AK. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J Biol Chem 2006; 281(17): 12132-42.
97. Rushmore TH. Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991; 266(18):11632-9.
98. Tong KI, Kobayashi A, Katsuoka F, Yamamoto M. Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism. Biol Chem 2006; 387:1311-20.
99. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22.
100. Abe J, Berk BC. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J Biol Chem 1999; 274(30): 21003-10.
101. Valco M, Leibfiritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human diseases. Int J Biochem Cell Biol 2007; 39: 44-84.
102. Haddad JJ. Hypoxia and the regulation of mitogen-activated protein kinases: Gene transcription and the assessment of potential pharmacologic therapeutic interventions. Int Immunopharmacol 2004; 4:1249-85.
103. McCubrey JA, LaHair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Anjioxid Redox Signal 2006; 8(9/10): 1775-89.
104. Koumenis C, Maxwell PH. Low oxygen stimulates the intellect: Symposium on hypoxia and development, physiology and disease. EMBO Rep 2006; 7(7): 679-84.
105. Hardie, D. G. New roles for the LKB1-AMPK pathway. Curr Opin Cell Biol 2005; 17: 167-73.
106. Reiling JH, Hafen E. The hypoxia-induced paralog Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev 2004; 18: 2879-92.
107. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004; 18(23): 2893-904.
108. Schieke SM, Phillips D, McCoy JP Jr, Aponte, AM, Shen R-F, Balaban RS, et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006; 281(37): 27643-52.
109. Tonks NK. Redox redux: Revisiting PTPs and the control of cell signaling. Cell 2005; 121(5):667-70.
110. Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ Res 2005; 97: 967-74.
111. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-78
112. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. In: Meister A Ed, Adv Enzymol volume 65. New York, Wiley and sons 1992; 287-347.
113. Hobbs AJ. Soluble guanylate cyclase: The forgotten sibling. Trends Pharmacol Sci 1997; 18: 484-91.
114. Traylor TG, Sharma VS. Why NO? Biochemistry 1992; 31(11) 2847-9.
115. Ignarro LJ. Nitric oxide: A unique endogenous signaling molecule in vascular biology (Nobel Lecture). Angew Chem Int Ed (1999); 38: 1882-92.
116. Andoh T, Chock PB, Chiueh CC. Preconditioning-mediated neuro-protection: Role of nitric oxide, cGMP, and new protein expression. Annals N Y Acad Sci 2002; 962: 1-7.
117. Andoh T, Chiueh CC, Chock PB. Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin per-oxidase-1 during homesis in response to oxidative stress-induced apoptosis. J Biol Chem 2003; 278(2): 885-90.
118. Holmqvist B, Ellingsen B, Forsell J, Zhdanova I, Alm P. The early ontogeny of neuronal nitric oxide synthase systems in the zebrafish. J Exp Biol 2004; 207(Pt6): 923-35.
119. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87-94.
120. James SL, Hibbs JB Jr. The role of nitric oxides as effector molecules of parasite killing. Parasitol Today 1990; 6: 303-5.
121. Farias-Eisner R, Sherman MP, Aeberhard E, Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci USA 1994; 91(20): 9407-11.
122. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 1999; 41: 131-41.
123. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat 1996; 10: 179-90.
124. Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 1993; 21: 330-4.
125. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arth Rheum 1993; 36: 1036-44.
126. Corbett JA, McDaniel AL. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41: 897-903.
127. Kroncke K-D, Brenner H-H, Rodrigue M-L, Etzkorn K, Noack EA, Kolb H, et al. Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. Biochim Biophys Acta 1993; 1182: 221-9.
128. Wink DA, Hanbauer I, Laval F, Cook JA, Krishna MC, Mitchell JB. Nitric oxide protects against the cytotoxic effects of reactive oxygen species. Ann NY Acad Sci 1993; 738: 265-78.
129. Wink DA, Hanbauer I, Krishna MC, DeGraft W, Gamson J, Mitchell JB. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 1993; 90(21): 9813-7.
130. Wink DA, Cook JA, Krishna MC, Hanbauer I, DeGraff W, Gamson J, et al. Nitric oxide protects against alkyl peroxide-mediated cytotoxicity: Further insights into the role nitric oxide plays in oxidative stress. Arch Biochem Biophys 1995; 319: 402-7.
131. Wink DA, Cook JA, Pacelli R, DeGraff W, Garrison J, Liebmann J, et al. The effect of various nitric oxide donor agents on hydrogen peroxide-mediated toxicity: A direct correlation between nitric oxide formation and protection. Arch Biochem Biophys 1996; 331(2): 241-8.
132. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991; 280(1): 130-6.
133. Kanner J, Harel S, Granit R. Nitric oxide, and inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992; 27(1): 46-9.
134. Kanner J. Nitric oxide and metal-catalyzed reactions. Methods Enzymol 1996; 269: 218-29.
135. Fukuto JM. Chemistry of nitric oxide: Biologically relevant aspects. Adv Pharmacol 1995; 134: 1-15.
136. Fukuto JM, Cho JY, Switzer CH. The chemical properties of nitric oxide and related nitrogen oxides (Chapter 2). In: Ignarro LJ Ed, Nitric oxide biology and pathobiology. San Diego, Academic Press 2000; 23-40.
137. Ford PC, Wink DA, Stanbury DM. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett 1993; 326(1,2,3): 1-3.
138. Liu X, Miller MJS, Joshi MS, Thomas DD, Lancaster JR. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA 1998; 95(5): 2175-9.
139. 2: A pulse radiolysis study. Free Rad Biol Med 1995; 19(4): 505-10.
140. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol Lung Cell Mol Physiol 1995; 268: L699-722.
141. Fukuto JM, Ignarro LJ. In Vivo aspects of nitric oxide (NO) chemistry: Does peroxynitrite (OONO) play a major role in cytotoxicity? Acc Chem Res 1997; 30 (4): 149-52.
142. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good. Free Rad Res 1999; 31: 651-69
143. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydrals. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266(7): 4244-50.
144. Gatti RM, Radi R, Augusto O. Peroxynitrite-mediated oxidation of albumin to the protein-thiyl free radical. FEBS Lett 1994; 348(3): 287-90.
145. Karoui H, Hogg N, Frejaville C, Tordo P, Kalyanaraman B. Characterization of sulfur-centered radical intermediates formed during the oxidation of thiols and sulfite by peroxynitrite. ESR-spin trapping and oxygen uptake studies. J Biol Chem 1996; 271(11): 6000-9.
146. Lymar SV, Hurst JK. Carbon dioxide: Physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant? Chem Res Toxicol 1996; 9(5): 845-50.
147. Uppu RM, Pryor WA. Carbon dioxide catalysis of the rection of peroxynitrite with ethyl acetoacetate: An example of aliphatic nitration by peroxynitrite. Biochem Biophys Res Commun 1996; 229(3): 764-9.
148. Zhang H, Squadrito GL, Uppu RM, Lemercier JL, Cueto R, Pryor WA. Inhibition of peroxynitrite-mediated oxidation of glutathione by carbon dioxide. Arch Biochem Biophys 1997; 339(1): 183-9.
149. Hoshino M, Ozawa K, Seki H, Ford PC. Photochemistry of nitric oxide adducts of water soluble iron(III) porphyrins and ferriberno-proteins by nanosecond laser photolysis. J Am Chem Soc 1993; 115(21): 9568-75.
150. Bouton C, Hirling H, Drapier JC. Redox modulation of iron regulatory proteins by peroxynitrite. J Biol Chem 1997; 272(32): 19969-75.
151. Misra RR, Hochadel JF, Smith GT, Cook JC, Waalkes MP, Wink DA. Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein. Chem Res Toxicol 1996; 9(1): 326-32.
152. Kroncke K-D, Fehsel K, Schmidt T, Zenke FT, Dasting I, Wesener JR, et al. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem Biophys Res Commun 1994; 200(2): 1105-10.
153. Crow JP, Beckman JS, McCord JM. Sensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochemistry 1995; 34(11): 3544-52.
154. Shinyashiki M, Chiang KT, Switzer CH, Gralla EB, Valentine JS, Thiele DJ, Fukuto JM. The interaction of nitric oxide (NO) with the yeast transcription factor Acel: A model system for NO-protein thiol interactions with implications to metal metabolism. Proc Natl Acad Sci USA 2000; 97(6): 2491-6.
155. Chiang KT, Shinyashiki M, Switzer CH, Valentine JS, Gralla EB, Thiele DJ, et al. Effetts of nitric oxide on the copper-responsive transcription factor Acel in Saccharomyces cerevisiae: Cytotoxic and cytoprotective actions of NO. Arch Biochem Biophys 2000; 377: 296-303.
156. Gow AJ, Buerk DG, Ischiropoulos H. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J Biol Chem 1997; 272(5): 2841-5
157. DeMaster EG, Redfern B, Quast BJ, Dahlseid T, Nagawawa HT. Mechanism for the inhibition of aldehyde dehydrogenase by nitric oxide. Alcohol 1997; 14(2): 181-89.
158. Zhao YL, Houk KN. Thionitoxides, RSNHO*: The structure of the SNO moiety in "S-Nitrosohemaglobin", a possible NO reservoir and transporter. J Am Chem Soc 2006; 128(5): 1422-3.
159. Cooper CE. Nitric oxide and iron proteins. Biochem Biophys Acta 1999; 1411(2-3): 290-309.
160. Rubbo H, Freeman BA. Nitric oxide regulation of lipid oxidation reactions: Formation and analysis of nitrogen-containing oxidized lipid derivatives. Methods Enzymol 1996; 269: 385-94.
161. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288(2): 481-7.
162. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncado S. The simultaneous-generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 1992; 17(1): 9-20.
163. Piantadosi CA. Biological chemistry of carbon monoxide. Antiox Red Sig 2002; 4: 259-70.
164. Young LJ, Caughey WS. Mitochondrial oxygenation of carbon monoxide. Biochem J 1986; 239: 225-7.
165. Vreman HJ, Wong RJ, Stevenson DK. Sources, sinks and measurements of carbon monoxide. In: Wang R. Ed, Carbon monoxide and cardiovascular functions. Boca Raton, CRC Press 2002; 45-65.
166. Platt JL, Nath KA. Herne oxygenase: Protective gene or Trojan horse. Nature Med 1998; 4: 1364-5.
167. Shibahara S, Kitamuro T, Takahashi K. Heme degradation and human disease: Diversity is the soul of life. Antioxid Redox Signal 2002; 4: 593-602.
168. Otterbein LE, Choi AMK.- The saga of leucine zippers continues in response to oxidative stress. Am J Respir Cell Mol Biol, 2000; 2: 161-3.
169. Morse D, Choi AMK. Heme oxygenase-1, the emerging molecule has arrived. Am J Resp Cell Mol Biol 2002; 27: 8-16.
170. Watanabe S, Akagi R, Mori M, Tsuchiya T, Sassa S. Marked developmental changes in heme oxygenase-1 (HO-1) expression in the mouse placenta: correlation between HO-1 expression and placental development. Placenta 2004; 25(5): 387-95.
171. Ortiz de Montellano PR. The mechanism of heme oxygenase. Curr Opin Chem Biol 2000; 2: 221-7.
172. Yoshida T, Migitar CT. Mechanism of heme degradation by heme xoygenase. J Inorg Biochem 2000; 82: 33-41.
173. Hangaishi M, Ishizaka N, Aizawa T, Kurihara Y, Taguchi J, Nagai R, et al. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 2000; 279: 582-8.
174. Katori M, Buelow R, Ke B, Ma J, Cotto AJ, Iyer S, et al. Heme-oxygenase overexpression protects rat hearts from cold ischemia/ reperfusion injury via an anti-apoptotic pathway. Transplantation 2002; 73: 287-92.
175. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella M, et al. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase. Circ Res 2001; 86: 1224-9.
176. Ke B, Buelow R, Shen X-D, Melinek J, Amersi F, Gao F, et al. Heme oxygenase 1 gene transfer prevents CD95/fas ligand-mediated apoptosis and improves allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 2002; 1: 1189-99.
177. Brouard S, Otterbain LE, Anrather J, Tobiasch E, Bach FH, Choi AMK, et al. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-25.
178. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 1999; 276: L688-94.
179. Fujita T, Toda K, Karimova A, Yan S-F, Naka Y, Yet S-F, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001; 7: 598-604.
180. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-8.
181. Nath KA. Heme oxygenase-1: A redoubtable response that limits reperfusion injury in the transplanted adipose liver. J Clin Invest 1999, 104(11): 1485-6.
182. Lee PJ, Jiang BH, Chin NV, Iyer J, Alam GL, Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase gene in response to hypoxia. J Biol Chem 1997; 272(9): 5375-81.
183. Rizzardini M, Terao M. Falciani F, Cantoni L. Cytokine induction of haem oxygenase mRNA in mouse liver: Interleukin 1 transcriptionally activates haem oxygenase. Biochem J 1993; 290: 343-7.
184. m for oxygen of nitric oxide synthase isoforms. J Pharmacol Exp Ther 1996; 276: 30-33
185. Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AM. Carbon monoxide modulates endotoxin-induced production of granulocyte colon stimulating
186. Song R, Ning W, Liu F, Ameredes BT, Calhoun WJ, Otterbein LE, et al. Regulation of IL-1beta-induced GM-CSF production in human airway smooth muscle cells by carbon monoxide. Am J Physiol Lung Cell Mol Physiol 2003; 284: L50-6.
187. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T, et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003; 278(39): 36993-8.
188. Wang R. Two's company, three's a crowd: Can H2S be the third endogenous gaseous transmitter? FASEB J 2002; 16(13): 1792-8.
189. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 2003; 5(4): 493-501.
190. Stanbury DM. Reduction potentials involving inorganic free radicals in aqueous solution. Adv Inorg Chem 1989; 33: 69-138.
191. Buettner GR. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol and ascorbate. Arch Biochem Biophys 1993; 300(2): 535-43.
192. Kamoun P. Endogenous production of hydrogen sulfide in mamals. Amino Acids 2004; 26: 243-54.
193. Banerjee R, Zou CG. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: A PLP-dependent hemesensor protein. Arch Biochem Biophys 2005; 433(1): 144-56.
194. Eto K, Kimura H. A novel enhancing mechanism for hydrogen sulfide-producing activity of cystathionine beta-synthase. J Biol Chem 2002; 277(45): 42680-5.
195. Deplancke B, Gaskins HR. Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 2003; 17(10): 1310-2.
196. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527-31.
197. ATP channel opener. EMBO J 2001; 20: 6008-16.
198. Taoka S, Banerjee R. Characterization of NO binding to human cystathionine beta-synthase: Possible implication of the effects of CO and NO binding to the human enzyme. J Inorg Biochem 2001; 87: 245-51
199. Zlotkin SH, Anderson GH. The development of cystathionase activity during the first year of life. Pediatr Res 1982; 16: 65-8.
200. Wrobel M, Ubuka T, Yao WB, Abe T. L-cysteine membolism in guinea pig and rat tissues. Comp Biochem Physiol 1997; 116B: 223-6.
201. Sturman JA, Gaull G, Raiha NC. Absence of cystathionase in human fetal liver: Is cystine essential? Science 1970, 169: 74-6.
202. Gaull G, Sturman JA, Raiha NC. Developm mammalian sulfur metabolism: absence of cystathionase in human fetal tissues. Pediatr Res 1972; 6: 538-47.
203. Levonen AL, Lapatto R, Saksela M, Raivio KO. Human cystathionine gamma lyase: Developmental and in vitro expression of two isoforms. Biochem J 2000; 347: 291-5.
204. Nagahara N, Ito T, Kitamura H, Nishino, T. Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: Confocal. laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis. Histochem Cell Biol, 1998; 110: 243-50.
205. Crawhall JC, Purkiss P, Stanbury JP. Metabolism of sulfur containing amino acids in a patient excreting β-mercaptolactate-cysteine disulfide. Biochem Med 1973; 7:103-11.
206. Sokolowska M, Wlodek L, Srebro Z, Wrobel M. The effect of nitrogen oxide level modulation on the content of thiol compounds and anaerobic sulfur metabolism in mice brains. Neurobiology 1999; 7: 461-77.
207. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006; 20(12): 2118-20.
208. Kimura M. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun 2000; 267: 129-33.
209. Leonard AS, Hell JS. Cyclic AMP-dependent protein kinase and protein kinase c phosphorylate N-methyl D-aspartate receptors at different sites. J Biol Chem 1997; 272(18): 12107-15.
210. Kimura M. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 2002; 26: 13-9.
211. Nagai Y, Tsugane M, Oka J, Kimura H. Hydrogen sulfide induces calcium waves in astrocytes. FASEB J 2004; 18: 557-9.
212. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol 2002; 283: H474-80.
213. Teague B, Asiedu S, Moore PK. The smooth muscle relaxant effect of hydrogen sulphide in vitro: Evidence for a physiological role to control intestinal contractility. Br J Pharmacol 2002; 137: 139-45.
214. Finol-Urdaneta RK, Struver N, Terlau H. Molecular and functional differences between heart mKv1.7 channel isoforms. J Gen Physiol 2006; 128(1): 133-45.
215. Liu Y, Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol 2002; 29(4): 305-11.
216. Dombkowski RA, Doellman MM, Head SK, Olson KR. Hydrogen sulfide mediates hypoxia-induced relaxation of trout urinary bladder smooth muscle. J Exp Biol 2006; 209(Pt. 16): 3234-40.
217. Olson KR, Dombkowski RA, Russell MJ, Doellman MM, Head SK, Whitfield NL, et al. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. J Exp Biol 2006; 209(Pt 20): 4011-23.
218. Whiteman M, Li L, Kostetsid I, Chu SH, Siau JL, Bhatia M, et al. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogeti sulphide. Biochem Biophys Res Commun 2006; 343(1): 303-110.
219. Huang LE, Willmore WG, Gu J, Goldberg MA, Bunn HF. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. J Biol Chem 1999; (13): 9038-44.
220. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, et al. Hypoxia-inducible factor-1 mediates tianscriptional activation of the heme oxygenase-1. J Biol Chem 1997; 272(9): 5375-81.
221. Ockaili R, Nataraja R, Salloam F, Fisher BJ, Jones D, Fowler AA III, et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation: Am J Physiol Heart Circ Physiol 2005; 289: H542-8.
222. Oh GS, Pae HO, Lee BS Kim BN, Kim JM, Kim MR, et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor kB via heme oxygenase-' expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Rad Biol Med 2006; 41: 106-19.
223. Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol Heart Circ Physiol 1987; 252: H721-32.
224. Wolin MS, Ahmad M, Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: Basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 2005; 289: L159-73.
225. Wu L, Wang R. Carbon monoxide: Endogenous production, physiological functions and pharmacological applications. Pharmacol Rev 2005; 57(4): 585-630.
226. Hartsfield CL, Alam J, Cook JL, Choi AMK. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol 1997; 273: L980-8.
227. Datta PK, Lianos EA. Nitric oxide induces heme oxygenase-1 gene expression in mesangial cells. Kidney Int 1999; 55(5): 1734-9.
228. Vitvitsky V, Mosharov E, Tritt M, Ataullakhanov F, Banerjee R. Redox regulation of homocysteine-dependent glutathione synthesis. Redox Rep 2003; 8(1): 57-63.
229. Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-senstitive stabilization of its alpha subunit. J Biol Chem 1996; 271(50): 32253-9.
230. Zuckerbraun BS, Chin BY, Bilban M, de Costa d'Avila J, Rao J, Billiar TR, et al. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J 2007; 21(4): 1099-106.
231. Antunes F, Cadenas E. The mechanisms of cytochrome c oxidase inhibition by nitric oxide. Front Biosci 2007; 12: 975-85.
232. 3. Isosteric and allosteric shifts of the reduced α-peak. Biochim Biophys Acta 1975; 396: 24-35.
233. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev 2005; 85(2): 571-633.
234. Davies KJA. The broad spectrum of responses to oxidants in proliferating cells: A new paradigm for oxidative stress. IUBMB Life 1999; 48: 41-7
235. Quinn P, Harlow GM. The effect of oxygen on the development of preimplantation mouse embryos in vitro. J Exp Zool 1978; 206: 73-80
236. Harvey AJ. The role of oxygen in rummant preimplantation embryo development and metabolism. Anim Reprod Sci 2007; 98: 113-28.
237. New DAT, Coppola PT. Effects of different oxygen concentrations on the development of rat embryos in culture. J Reprod Fertil 1970; 21: 109-18.
238. New DAT, Coppola PT. Development of explanted rat fetuses in hyperbaric oxygen. Teratology 1970; 3: 153-62.
239. Jenkinson PC, Anderson D, Gangolli SD. Malformations induced in cultured rat embryos by enzymatically generated active oxygen species. Teratog Carcinog Mutagen 1986; 6: 547-54.
240. Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species. FASEB J 1997; 11: 388-95.
241. Robkin MA. Carbon monoxide and the embryo. Int J Dev Biol 1997; 41(2):283-9.
242. Ferm VH. Teratogenic effects of hyperbaric oxygen. Proc Soc Exp Biol Med 1964; 116: 975-6.
243. Grote W, Wagner WD. Malformations in rabbits following hyperbaric oxygenation. Klin Wochenschr 1973; 51: 248-50.
244. Fujikura R. Retrolental fibroplasias and prematurity in newborn rabbits induced by maternal hyperoxia. Am J Obstet Gynecol 1964; 90: 854-8.
245. Chandel NS, Budinger GR. The cellular basis for diverse responses to oxygen. Free Rad Biol Med 2007; 42(2): 165-74.
246. Siner JM, Jiang G, Cohen ZI, Shan P, Zhang X, Lee CG, et al. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J 2007; 21(7): 1422-32.
247. Wang X, Wang Y, Jiang G, Zhang SS, Otterbein LE, Fu XY, et al. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 2007; 282(3):1718-26.
248. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 2004; 287: L344-51.
249. Cotton RB, Sundell HW, Zeldin DC, Morrow JD, Roberts LJ, Hazinski TA, et al. Inhaled nitric oxide allenuates hyperoxic lung injury in lambs. Pediatr Res 2006; 59(1): 142-6.
250. Fantel AG, Mackler B, Stamps LD, Tran TT, Person RE. Reactive oxygen species and DNA oxidation in fetal rat tissues. Free Rad Biol Med 1998; 25: 95-103.
251. Machado AF, Scott WJ, Collins MD. Reactive oxygen species in the production of congenital malformations by known teratogenic agents and maternal conditions. In: Forman HJ, Fukuto J, Torres M Eds, Signal transduction by reactive oxygen and nitrogen species: Pathways and chemical principles. Boston, Kluwer 2003; 379-406.
252. Wells, PG, Bhuller Y, Chen CS, Jeng W, Kasapinovic S, Kennedy JC, et al.. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol Appl Pharmacol 2005; 207: S354-66.
253. Grabowski CT. Embryonic oxygen deficiency: A physiological approach to analysis of teratological mechanism. Adv Teratol 1970; 4: 125-67.
254. Harris C. Hypoxia and altered redox status in embryotoxicity. Handbook Exp Pharmacol 1997; 124/I: 519-48.
255. Feil D, Lane M, Roberts CT, Kelley RL, Edwards LJ, Thompson JG, et al. Effect of culturing mouse embryos under different oxygen concentrations on subsequent fetal and placental development. J Physiol 2006; 572(Part 1): 87-96.
256. Ingalls TH, Curley FJ, Prindle RA. Experimental production of congenital abnormalities: Timing and degree of anoxia as factors causing fetal deaths and congenital abnormalities in the mouse. N Engl J Med 1952; 247: 758-68.
257. Rübsaamen H. Uber die teratogenetische Wirkung des Sauerstoffinangels in der Frühentwicklung. Ein Beitrag zur Kauselgenese der Missbildungen bei Mench und Tier. Beitr Pathol Anat 1952; 112: 336-79.
258. Ingalls TH, Curley FJ. Principles governing the genesis of congenital malformations induced in mice by hypoxia. N Engl J Med 1957; 257: 1121-7.
259. Grabowski CT, Parr JA. The teratogenic effects of graded doses of hypoxia on the chick embryo. Am J Anat 1958; 103: 313-48.
260. Degenhardt KH, Knoche E. Analysis of intrauterine malformations of vertebral column induced by oxygen deficiency. Can Med Assoc J 1959; 80:441-5.
261. Shang EH, Wu RS. Aquatic hypoxia is a teratogen and affects fish embryonic development. Environ Sci Technol 2004; 38(18): 4763-7.
262. Teodoro RO, O'Farrell PH. Nitric oxide-induced suspended animation promotes survival during hypoxia. EMBO J 2003; 22(3): 580-7.
263. Büchner F. Differenzierungsstörungen im mittleren und hinteren Korperdrittel des Hühnchens nach experimentellen Sauerstoffmangel in der Frühentwicklung. Beitr Pathol Anat 1955; 115: 617-43.
264. Grabowski CT. A quantitative study of the lethal and teratogenic effects of hypoxia on the three-day chick embryo. Am J Anat 1961; 109: 25-36.
265. Greenaway JC, Fantel A, Juchau MR. On the capacity of nitroheterocyclic compounds to elicit an unusual axial asymmetry in cultured rat embryos. Toxicol Appl Pharmacol 1986; 82: 307-5.
266. Mirkes PE, Little SA. Teratogen-induced cell death in postimplantation mouse embryos: Differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ 1998; 5(7): 592-600.
267. Padmanabhan, R, Al-Menhali NM, Tariq S, Shafiullah M. Mitochondrial dysmorphology in the neuroepithelium of rat embryos following a single dose of maternal hyperthermia during gestation. Exp Brain Res 2006; 173(2): 298-308.
268. Brent RL, Franklin JB. Uterine vascular clamping: New procedure for the study of congenital maltormations. Science 1960; 132: 88-91.
269. Leist KH, Grauwiler J. Fetal pathology in rats following uterine vessel clamping on day 14 of gestation. Teratology 1974; 10: 55-68.
270. Millicovsky G, DeSesso JM. Differential embryonic cardiovascular responses to acute maternal uterine ischemia: An in vivo microscopic study of rabbit embryos with either intact or clamped umbilical cords. Teratology 1980; 22: 335-43.
271. Webster WS, Lipson AH, Brown-Woodman PDC. Uterine trauma and limb defects. Teratology 1987; 35: 253-60.
272. Mills E, Jobsis FF. Mitochondrial respiratory chain of carotid body and chemoreceptor response to changes in oxygen tension. J Neurophysiol 1972; 35(4): 405-28.
273. Chacon E, Reece JM, Nieminen A-L, Zahrebelski G, Herman B, Lemasters JJ. Distribution of electrical potential, pH, free Ca+2, and volume inside cultured adult rabbit cardiac myocytes during chemical hypoxia: A multiparameter digitized confocal microscopic study. Biophys J 1994; 66: 942-52.
274. Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase-development of the energy sensor concept. J Physiol 2006; 574(Pt 1): 7-15.
275. Lemasters JJ, Holmuhamedov E. Voltage-dependent anion channel (VDAC) as mitochondrial governator - thinking outside the box. Biochim Biophys Acta 2006; 1762(2): 181-90.
276. Comellas AP, Dada LA, Lecuona E, Pesce LM, Chandel NS, Quesada N, et al. Hypoxia-mediated degradation of Na,K-ATPase via mitochondrial reactive oxygen species and the ubiquitin-conjugating system. Circ Res 2006; 98(10): 1314-22.
277. Mackler B, Grace R, Duncan HM. Studies of mitochondrial development during embryogenesis in the rat. Arch Biochem Biophys 1971; 144(2): 603-10.
278. Mackler B, Grace R, Haynes B, Bargman GJ, Shepard TH. Studies of mitochondrial energy systems during embryogenesis in the rat. Arch Biochem Biophys 1973; 158(2): 662-6.
279. Bell EL, Emerling BM, Chandel NS. Mitochondrial regulation of oxygen sensing. Mitochondrion 2005; 5(5): 322-32.
280. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3(3): 187-97.
281. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Fould R, McMaster M, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004; 114(6): 744-54.
282. Jaffe OC. The effects of moderate hypoxia and moderate hypoxia plus hypercapnea on cardiac development in chick embryos. Teratology 1974; 10: 275-81.
283. Sharma SK, Lucitti JL, Nordman C, Tinney JP, Tobita K, Keller BB. Impact of hypoxia on early chick embryo growth and cardiovascular functions. Pediatr Res 2006; 59(1): 116-20.
284. van Tuyl M, Liu J, Wang J, Kuliszewski M, Tibboel D, Post M. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am J Physiol Lung Cell Mol Physiol 2005; 288: L167-78.
285. Miao CY, Zuberbuhler JS, Zuberbuhler JR. Prevalence of congenital cardiac anomalies at high altitude. J Am Coll Cardiol 1988; 12: 224-8
286. Ramirez-Bergeron DL, Runge A, Dahl KD, Fehling HJ, Keller G, Simon MC. Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 2004; 131(18): 4623-34.
287. Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 2005; 102(13): 4783-98.
288. Mortola JP, Gautier H. Interaction between metabolism and ventilation: effects of respiratory gases and temperature. In: Dempsey JA, Pack AI Eds, Regulation of breathing (2nd Edition). New York, NY, Marcel Dekker 1995; 1011-64.
289. Mortola JP, Besterman AD. Gaseous metabolism of the chicken embryo and hetchling during post-hypoxic recovery. Respir Physiol Neurobiol 2007; 156(2): 212-9.
290. Zechel JL, Gamboa JL, Peterson AG, Puchowicz MA, Selman WR, Lust WD. Neuronal migration is transiently delayed by prenatal exposure to intermittent hypoxia. Birth Defects Res B Dev Reprod Toxicol 2005; 74(4): 287-99.
291. Cao C, Leng Y, Kufe D. Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem 2003; 278(32): 29667-75
292. Cao C, Leng Y, Liu X, Yi Y, Li P, Kufe D. Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. Biochemistry 2003; 42: 10348-53.
293. Li R, Chase M, Jung SK, Smith PJ, Loeken MR. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 2005; 289(4): E591-5.
294. Webster WS, Howe AM, Abela D, Oakes DJ. The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin. Curr Pharm Des 2006; 12(12): 1431-48.
295. Abela D, Howe AM, Oakes DA, Webster WS. Maternal antioxidant supplementation does not reduce the incidence of phenytoin-induced cleft lip and related malformations in rats. Birth Defects Res B Dev Reprod Toxicol 2005; 74(2): 201-6.
296. Azarbayjani F, Borg H, Danielsson BR. Increased susceptibility to phenytoin teratogenicity: Excessive generation of reactive oxygen species or impaired antioxidant defense? Basic Clin Pharmacol Toxicol 2006; 99(4): 305-11.
297. Millicovsky G, Johnston MC. Maternal hyperoxia greatly reduces the incidence of phenytoin-induced cleft lip and palate in A/J mice. Science 1981; 212(4495): 671-2.
298. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, et al. Cellular and developmental control of O2 homeostasis by by-poxia-inducible factor 1 alpha. Genes Dev 1998; 12: 149-62.
299. Kotch LE, Iyer NV, Laughner E, Semenza GL. Defective vascularization of HIF-1α-null embryos is not associated with VEGF deficiency byt with mesenchymal cell death. Dev Biol 1999; 209: 254-67.
300. Compernolle V, Brusselmans K, Franco P, Moorman A, Dewerchin M, Collen D, et al. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc Res 2003; 60: 569-79.
301. Sulik KK, Cook CS, Webster WS. Teratogens and craniofacial malformations: Relationship to cell death. Development 1988; 103(Suppl.): 213-31.
302. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-9.
303. Carmeliet P, Dor Y, Herbert J-M, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumour angiogenesis. Nature 1998; 394: 485-90.
304. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-42.
305. Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/ hypoxia- inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci USA 2000; 97(15): 8386-91.
306. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, et al. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatement with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002; 8: 702-10.
307. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The hypoxia responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998; 12: 3320-4.
308. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997; 386: 403-7.
309. Kozak KR, Abbott B, Hankinson O. ARNT-deficient mice and placental differentiation. Dev Biol 1997; 191: 297-305.
310. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroylase domain protein 2. Mol Cell Biol 2006; 26(22): 8336-46.
311. Adelman DM, Gertsenstein M, Nagy A, Simon MC, Maltepe E. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev 2000; 14: 3191-203.
312. Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 1997; 94(17): 9102-7.
313. Gouge RC, Marshburn P, Gordon BE, Nunley W, Huet-Hudson YM. Nitric oxide as a regulator of embryonic development. Biol Reprod 1998; 58: 875-9.
314. Sengoku K, Takuma N, Horikawa M, Tsuchiya K, Komori H, Sharifa D, et al. Requirement of nitric oxide for murine oocyte maturation, embryo development, and trophoblast outgrowth in vitro. Mol Reprod Dev 2001; 58(3): 262-8.
315. Orsi NM. Embryotoxicity of the nitric oxide donor sodium nitroprusside in preimplantation bovine embryos In vitro. Animal Reprod Sci 2006; 91: 225-36.
316. Lee QP, Juchau MR. Dysmorphogenic effects of nitric oxide (NO) and NO-synthase inhibition: Studies with intra-amniotic injections of sodium nitroprusside and NG-monomethyl-L-arginine. Teratology 1994; 49: 452-64.
317. Lee QP, Park HW, Thayer J, Mirkes PE, Juchau MR. Apoptosis induced in cultured rat embryos by intra-amniotically microinjected sodium nitroprusside. Teratology 1996; 53(1): 21-30.
318. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, et al. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 1994; 171: 1243-50.
319. Pierce RL, Pierson DL, Liu H, Kadowitz PJ, Miller MJS. Limb reduction defects after prenatal inhibition of nitric oxide synthase in rats. Pediatr Res 1995; 38: 905-11.
320. Fantel AG, Nekabi N, Shepard TH, Cornel LM, Unis AS, Lemire RJ. The teratogenicity of N-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor in rats. Reprod Toxicol 1997; 11: 709-17.
321. Fantel AG, Stamps LD, Tran TT, Mackler B, Person RE, Nekahi N. Role of free radicals in the limb teratogenicity of L-Name (N-nitro-L-arginine methyl ester): A new mechanistic model of vascular disruption. Teratology 1999; 60: 151-60.
322. Fantel AG, Stamps LD, Tran TT, Mackler B, Person RE, Nekahi N. Free radical formation and toxicity in the limb teratogenicity of L-NAME: A new mechanistic model of vascular disruption. Teratology 2000; 62: 237.
323. Fantel AG, Person RE. Involvement of mitochondria and other free radical sources in normal and abnormal fetal development. Ann NY Acad Sci 2002; 959: 424-33.
324. Tiboni GM, Giampietro F, Di Giulio C. The nitric oxide synthesis inhibitor N-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: Protective effects of acute hyperoxia. Ped Res 2003; 54: 69-76.
325. Tiboni GM, Clementini E. Teratological consequences of nitric oxide synthesis inhibition. Curr Pharm Des 2004; 10: 2759-67.
326. G-nitro-L-arginine methyl ester (L-NAME) in the mouse. Birth Defects Res B Dev Reprod Toxicol 2007; 80(1): 28-33.
327. van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001; 103: 255-61.
328. Alexander PG, Tuan RS. Carbon monoxide-induced axial skeletal dysmorphogenesis in chick embryo. Birth Defects Res Part A Clin Mol Teratol 2003; 67: 219-30.
329. Nath AK, Madri JA. The roles of nitric oxide in murine cardiovascular development. Dev Biol 2006; 292: 25-33.
330. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, Hescheler J, et al. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 1999; 43(3): 675-84.
331. Nath AK, Enciso J, Kuniyasu M, Hao X-Y, Madri JA, Pinter E. Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development 2004; 131: 2485-96.
332. Gregg AR, Schauer A, Shi O, Liu Z, Lee CGL, O'Brien WE. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol 1998; 275: H2319-24.
333. Hefler LA, Reyes CA, O'Brien WE, Gregg AR. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod 2001; 64: 666-73.
334. Lee TC, Zhao YD, Courtman DW, Stewart DJ. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000; 101: 2345-8.
335. Feng O, Song W, Lu X, Hamilton JA, Lei M, Peng T, et al. Development of heart failure and congenital defects in mice lacking endothelial nitric oxide synthase. Circulation 2002; 106: 873-9.
336. Fisher SA, Langille BL, Srivastava D. Apoptosis during cardiovascular development. Circ Res 2000; 87: 856-64.
337. Gelb BD, Zhang J, Sommer SO, Wasserman JM, Reitman, MJ, Willner JP. Familial patent ductus arteriosus and bicuspid aortic valve with hand abnormalities: A novel heart-hand syndrome. Am J Med Genet 1999; 87: 175-9.
338. Brown KS, Cook M, Hoess K, Whitehead AS, Mitchell LE. Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Res Part A Clin Mol Teratol 2004; 70: 101-6.
339. Carmichael SL, Shaw GM, Yang W, Iovannisci DM, Lammier E. Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1 and NOS3 genetic variants, maternal smoking, and vitamin supplement intake. Am J Med Genet A 2006; 140: 1915-22.
340. Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, et al. Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol 2005; 162: 1207-14.
341. Tiboni GM, Lamonaca D. Transplacental exposure to methylene blue initiates teratogenesis in the mouse: Preliminary evidence for a mechanistic implication of cyclic GMP pathway disruption. Teratology 2001; 64: 213-20.
342. Tiboni GM, Giampietro F, Lamonaca D. The soluble guanylate cyclase inhibitor methylene blue evokes preterm delivery and fetal growth restriction in a mouse model. In Vivo 2001; 15: 333-7.
343. Hofmann F, Feil R, Kleppisch T, Schlossmann J. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 2006; 86: 1-23.
344. Kwon YT, Kashina AS, Davydov IV, Hu R-G, An JY, Seo JW, et al. An essential role of N-terminal arginylation in cardiovascular development. Science 2002; 297: 96-9.
345. Hu R-G, Sheng J, Qi X, Xu Z, Takahashi TT, Varshavsky A. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 2005; 437(7061): 981-6.
346. Metzen E, Zhou J, Jelkmann W, Fandrey J, Brune B. Nitric oxide impairs normoxic degradation of HIF-1a by inhibition of prolyl hydroxylases. Mol Biol Cell 2003; 14(8): 3470-81.
347. Dulak J, Jozkowicz, A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antioxid Redox Signal 2003; 5: 123-32.
348. Wells LL. The prenatal effect of carbon monoxide on albino rats and the resulting neuropathology. Biologist 1933; 15: 80-1.
349. Astrup P, Olsen HM, Trolle D, Kjeldsen, K. Effect of moderate carbon-monoxide exposure on fetal development. Lancet 1972; 2(7789): 1220-2.
350. Astrup P, Trolle D, Olsen HM, Kjeldsen K. Moderate hypoxia exposure and fetal development. Arch Environ Health 1975; 30(1): 15-6.
351. Schwetz BA, Smith FA, Leong BKJ, Staples RE. Teratogenic potential of inhaled carbon monoxide in mice and rabbits. Teratology 1979; 19: 385-91.
352. Murray FJ, Schwetz BA, Crawford AA, Henck JW, Quast JF, Staples RE. Embryotoxicity of inhaled sulfur dioxide and carbon monoxide in mice and rabbits. J Environ Sci Health C 1979; 13(3): 233-50.
353. Bailey LJ, Johnston MC, Billet, J. Effects of carbon monoxide and hypoxia on cleft lip in AJ mice. Cleft-Pal Craniofac J 1995; 32: 14-9.
354. Loder RT, Hernandez MJ, Lerner AL, Winebrener DJ, Goldstein SA, Hensinger RN, et al. The induction of congenital spinal deformities in mice by maternal carbon monoxide exposure. J Ped Ortho 2000; 20: 662-6.
355. Daughtrey WC, Newby-Schmidt MB, Norton S. Forebrain damage in chick embryos exposed to carbon monoxide. Teratology 1983; 28: 83-9.
356. Bnait KS, Seller MJ. Ultrastructural changes in 9-day old mouse embryos following maternal tobacco smoke inhalation. Exp Toxicol Pathol 1995;.47: 453-61.
357. Baker FD, Tumasonis CF. Carbon monoxide and avian embryogenesis. Arch Environ Health 1972; 24: 53-61.
358. Poss KD, Thomas MJ, Ebralidze, AK, O'Dell TJ, Tonegawa S. Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron 1995; 15: 867-73.
359. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron metabolism. Proc Natl Acad Sci USA 1997; 94(20): 10919-24.
360. Singh J. Gastroschisis is caused by the combination of carbon monoxide and protein-zinc deficiencies. Birth Defects Res B Dev Reprod Toxicol 2003; 68(4): 355-62.
361. Singh J. Interaction of maternal protein and carbon monoxide on pup mortality in mice: Implications for global infant mortality. Birth Defects Res B Dev Reprod Toxicol 2006; 77(3): 216-26.
362. Boczkowski J, Poderoso JJ, Motterlini R. CO-metal interaction: Vital signaling from a lethal gas. Trends Biochem Sci 2006; 31 (11): 614-21
363. Ritz B, Yu F, Fruin S, Chapa G, Shaw GM, Harris JA. Ambient air pollution and risk of birth defects in Southern California. Am J Epidem 2002; 155: 17-25.
364. Chadefaux B, Rethore MO, Raoul 0, Ceballos I, Poissonnier M, Gilgenkrantz S, et al. Cystathionine beta synthase: Gene dosage effect in trisomy 21. Biochem Biophys Res Commun 1985; 128(1): 40-4
365. Kamoun P. Mental retardation in Down syndrome: A hydrogen sulfide hypothesis. Med Hypoth 2001; 57: 399-92.
366. Lloyd D. Hydrogen sulfide: Clandestine microbial messenger? Trends Microbiol 2006; 14(10): 456-62.
367. Evans CL. Thp toxicity of hydrogen sulfide and other sulfides. J Exp Physiol 1967; 52:231-48.
368. Finklea JF. Criteria for a recommended standard occupational exposure to hydrogen sulfide, DWEW (NIOSH) 1997; 77-158.
369. Smith RP, Gossetin RE. Hydrogen sulfide poisoning. J Occup Med 1979; 21: 93-7.
370. Winder CV, Winder HO. The scat of action of sulfide on pulmonary ventilation. Am J Physiol 1933; 105: 337-52.
371. Truong DH, Eghbal MA, Hindmarsh W, Roth SH, O'Brien, PJ. Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab Rev 2006; 38(4): 733-44.
372. Lloyd D, Murray DB. The temporal architecture of eukaryotic growth. FEBS Lett 2006; 586: 2830-5.
373. Kuzin B, Roberts I. Peunova N, Enikolopov G. Nitric oxide regulates cell proliferation during Drosophila development. Cell 1996; 87(4): 639-49
374. Nystul TG, Goldmark JP, Padilla PA, Roth MB. Sdspended animation in C. elegans requires the spindle checkpoint. Science 2003; 302(5647):1038-41.
375. Nystul TG, Roth MB, Carbon monoxide-induced suspended animation protects against hypoxic damage in Caenorhabditis elegans. Proc Natl Acad Sci USA 2004; 101(24): 9133-36.
376. Flick B, Klug S. Whole embryo culture: An important tool in developmental toxicology today. Curr Pharm Des 2006; 12(12): 1467-88
377. Giles JJ, Bannigan JG. Teratogenic and developmental effects of lithium. Curr Pharm Des 2006; 12(12): 1531-41.
378. Nagle DG, Zhou YD, Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1). Curr Pharm Des 2006; 12(21): 2673-88.